$938 Million is the total value of Consonance Capital Management LP's 35 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 65.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $93,364,000 | +16.3% | 558,162 | +5.5% | 9.95% | +32.7% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $88,387,000 | +36.4% | 1,201,399 | +34.5% | 9.42% | +55.7% |
| MGNX | Buy | MACROGENICS INC | $78,747,000 | +49.8% | 2,472,447 | +7.5% | 8.40% | +71.0% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $70,181,000 | +27.5% | 2,709,709 | -0.7% | 7.48% | +45.6% |
| KROS | Buy | KEROS THERAPEUTICS INC | $54,792,000 | +39.4% | 890,209 | +59.8% | 5.84% | +59.2% |
| AFMD | New | AFFIMED N V | $47,531,000 | – | 6,008,974 | +100.0% | 5.07% | – |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $44,567,000 | +61.1% | 993,912 | +105.1% | 4.75% | +83.9% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $43,716,000 | -39.7% | 255,203 | -22.7% | 4.66% | -31.2% |
| TPTX | New | TURNING POINT THERAPEUTICS I | $42,603,000 | – | 450,396 | +100.0% | 4.54% | – |
| GMED | Sell | GLOBUS MED INCcl a | $35,668,000 | -39.8% | 578,371 | -36.4% | 3.80% | -31.3% |
| ARVN | Buy | ARVINAS INC | $30,406,000 | -15.8% | 460,000 | +8.2% | 3.24% | -3.9% |
| VSTM | Buy | VERASTEM INC | $27,667,000 | +67.0% | 11,201,412 | +44.0% | 2.95% | +90.5% |
| GMDA | Buy | GAMIDA CELL LTD | $26,844,000 | -2.7% | 3,318,207 | +0.9% | 2.86% | +11.1% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $26,020,000 | – | 896,608 | +100.0% | 2.77% | – |
| CASI | Buy | CASI PHARMACEUTICALS INC | $25,298,000 | +13.2% | 10,540,715 | +39.1% | 2.70% | +29.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $25,018,000 | -68.5% | 790,197 | -53.8% | 2.67% | -64.0% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $23,971,000 | -65.4% | 1,669,293 | -52.7% | 2.56% | -60.6% |
| STXS | Buy | STEREOTAXIS INC | $23,578,000 | +47.8% | 3,508,676 | +11.9% | 2.51% | +68.7% |
| INFI | New | INFINITY PHARMACEUTICALS INC | $21,237,000 | – | 6,575,000 | +100.0% | 2.26% | – |
| NKTX | New | NKARTA INC | $18,761,000 | – | 570,255 | +100.0% | 2.00% | – |
| ACET | New | ADICET BIO INC | $15,917,000 | – | 1,216,860 | +100.0% | 1.70% | – |
| CFMS | New | CONFORMIS INC | $12,870,000 | – | 13,000,000 | +100.0% | 1.37% | – |
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $9,760,000 | -6.8% | 1,000,000 | 0.0% | 1.04% | +6.3% | |
| SIOX | SIO GENE THERAPIES INC | $8,316,000 | -6.1% | 3,186,335 | 0.0% | 0.89% | +7.3% | |
| CTIC | CTI BIOPHARMA CORP | $7,312,000 | -9.6% | 2,512,800 | 0.0% | 0.78% | +3.0% | |
| CLRB | CELLECTAR BIOSCIENCES INC | $6,559,000 | -22.6% | 4,074,074 | 0.0% | 0.70% | -11.6% | |
| IMGN | Sell | IMMUNOGEN INC | $5,701,000 | -74.9% | 703,790 | -80.0% | 0.61% | -71.3% |
| SLN | New | SILENCE THERAPEUTICS PLCads | $5,111,000 | – | 222,222 | +100.0% | 0.54% | – |
| RACB | New | RESEARCH ALLIANCE CORP II | $3,075,000 | – | 300,000 | +100.0% | 0.33% | – |
| DFHTU | Sell | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $3,010,000 | -19.7% | 229,800 | -8.1% | 0.32% | -8.3% |
| MSACU | New | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $2,955,000 | – | 300,000 | +100.0% | 0.32% | – |
| JYAC | JIYA ACQUISITION CORP | $2,952,000 | -4.5% | 300,000 | 0.0% | 0.32% | +9.0% | |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $2,618,000 | – | 250,000 | +100.0% | 0.28% | – |
| BCTG | BCTG ACQUISITION CORP | $2,002,000 | -2.8% | 180,000 | 0.0% | 0.21% | +10.9% | |
| HLXA | HELIX ACQUISITION CORP | $1,530,000 | -9.2% | 150,000 | 0.0% | 0.16% | +3.8% | |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -6,073 | -100.0% | -0.03% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -39,697 | -100.0% | -0.06% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -88,428 | -100.0% | -0.06% | – |
| FSDC | Exit | FS DEV CORP | $0 | – | -100,000 | -100.0% | -0.10% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -1,558,290 | -100.0% | -0.28% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -610,000 | -100.0% | -0.64% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -387,492 | -100.0% | -0.94% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -1,969,875 | -100.0% | -1.11% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -2,373,924 | -100.0% | -1.53% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -631,215 | -100.0% | -2.55% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -7,349,621 | -100.0% | -2.85% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -1,401,703 | -100.0% | -3.48% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -4,480,163 | -100.0% | -6.11% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -584,885 | -100.0% | -6.66% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 29 | Q2 2022 | 15.9% |
| ADMA BIOLOGICS INC | 27 | Q4 2020 | 2.3% |
| RETROPHIN INC | 23 | Q1 2020 | 11.3% |
| ANI PHARMACEUTICALS INC | 23 | Q3 2019 | 7.9% |
| VERICEL CORP | 21 | Q4 2019 | 5.5% |
| AMARIN CORP PLC | 14 | Q3 2019 | 14.4% |
| GLOBUS MED INC | 13 | Q2 2022 | 24.7% |
| ORTHOFIX INTL N V | 13 | Q3 2016 | 9.7% |
| PACIFIC BIOSCIENCES CALIF IN | 13 | Q4 2018 | 9.7% |
| CATALYST PHARM PARTNERS INC | 13 | Q3 2019 | 9.4% |
View Consonance Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | December 15, 2022 | 0 | 0.0% |
| ADMA BIOLOGICS, INC. | February 14, 2022 | 1,289,481 | 1.4% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| CASI Pharmaceuticals, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Cellectar Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Gamida Cell Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| GenMark Diagnostics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Protagonist Therapeutics, IncSold out | February 14, 2022 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Consonance-HFW Acquisition Corp. | April 27, 2021 | 1,000,000 | 10.4% |
View Consonance Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-12-15 |
| SC 13D/A | 2022-12-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Consonance Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.